Literature DB >> 36245657

Seeing the Light: Improving Diabetic Retinopathy Outcomes by Bringing Screening to the Dialysis Clinic.

Klara R Klein1, Jennifer E Flythe2,3.   

Abstract

Entities:  

Keywords:  diabetes; diabetes and the kidney; diabetic retinopathy; dialysis; glycemia; kidney failure

Mesh：

Year:  2022        PMID： 36245657      PMCID： PMC9528370          DOI： 10.34067/KID.0003752022

Source DB:  PubMed          Journal:  Kidney360        ISSN： 2641-7650


× No keyword cloud information.
  22 in total

Review 1.  The Use of HbA1c, Glycated Albumin and Continuous Glucose Monitoring to Assess Glucose Control in the Chronic Kidney Disease Population Including Dialysis.

Authors:  Tobias Bomholt; Therese Adrian; Kirsten Nørgaard; Ajenthen G Ranjan; Thomas Almdal; Anders Larsson; Mette Vadstrup; Marianne Rix; Bo Feldt-Rasmussen; Mads Hornum
Journal:  Nephron       Date:  2020-12-02       Impact factor: 2.847

2.  Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis.

Authors:  Zhen Ling Teo; Yih-Chung Tham; Marco Chak Yan Yu; Miao Li Chee; Tyler Hyungtaek Rim; Ning Cheung; Mukharram M Bikbov; Ya Xing Wang; Yating Tang; Yi Lu; Ian Yat Hin Wong; Daniel Shu Wei Ting; Gavin Siew Wei Tan; Jost B Jonas; Charumathi Sabanayagam; Tien Yin Wong; Ching-Yu Cheng
Journal:  Ophthalmology       Date:  2021-04-30       Impact factor: 12.079

3.  How effective are treatments for diabetic retinopathy?

Authors:  F L Ferris
Journal:  JAMA       Date:  1993-03-10       Impact factor: 56.272

Review 4.  Novel approaches to hypoglycemia and burnt-out diabetes in chronic kidney disease.

Authors:  Connie M Rhee; Kamyar Kalantar-Zadeh; Katherine R Tuttle
Journal:  Curr Opin Nephrol Hypertens       Date:  2022-01-01       Impact factor: 2.894

5.  Factors Associated With Nonattendance in a Nationwide Screening Program for Diabetic Retinopathy: A Register-Based Cohort Study.

Authors:  Gabriela B Petersen; Stine Byberg; Dorte Vistisen; Mia V Fangel; Henrik Vorum; Lene E Joensen; Jette K Kristensen
Journal:  Diabetes Care       Date:  2022-02-01       Impact factor: 19.112

6.  Fragmentation of care as a barrier to optimal ESKD management.

Authors:  Caroline E Sloan; Judy Zhong; Dinushika Mohottige; Rasheeda Hall; Clarissa J Diamantidis; Leight E Boulware; Virginia Wang
Journal:  Semin Dial       Date:  2020-10-31       Impact factor: 3.455

7.  Pharmacokinetics and Tolerability of a Single Dose of Semaglutide, a Human Glucagon-Like Peptide-1 Analog, in Subjects With and Without Renal Impairment.

Authors:  Thomas C Marbury; Anne Flint; Jacob B Jacobsen; Julie Derving Karsbøl; Kenneth Lasseter
Journal:  Clin Pharmacokinet       Date:  2017-11       Impact factor: 6.447

Review 8.  Diabetic Retinopathy: A Position Statement by the American Diabetes Association.

Authors:  Sharon D Solomon; Emily Chew; Elia J Duh; Lucia Sobrin; Jennifer K Sun; Brian L VanderBeek; Charles C Wykoff; Thomas W Gardner
Journal:  Diabetes Care       Date:  2017-03       Impact factor: 19.112

9.  Reported Cases of End-Stage Kidney Disease - United States, 2000-2019.

Authors:  Nilka Ríos Burrows; Alain Koyama; Meda E Pavkov
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2022-03-18       Impact factor: 17.586
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.